Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor

Strunz PP, Schmalzing M, Heidemeier A, Rasche L, Einsele H, Kortuem KM (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Leukemia & Lymphoma Informa Healthcare

Book Volume: 60

Pages Range: 3573-3576

Journal Issue: 14

DOI: 10.1080/10428194.2019.1636981

Involved external institutions

Universitätsklinikum Würzburg DE Germany (DE)

How to cite

APA:

Strunz, P.-P., Schmalzing, M., Heidemeier, A., Rasche, L., Einsele, H., & Kortuem, K.M. (2019). Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor. Leukemia & Lymphoma, 60(14), 3573-3576. https://doi.org/10.1080/10428194.2019.1636981

MLA:

Strunz, Patrick-Pascal, et al. "Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor." Leukemia & Lymphoma 60.14 (2019): 3573-3576.

BibTeX: Download